April 21, 2015 by 2012pharmaceutical
New BP guidelines reduce antihypertensive therapy eligibility by 6 million … – Healio
Reporter: Aviva Lev-Ari, PhD, RN
SAN DIEGO — The number of patients in the US who would be eligible for antihypertensive therapy decreases by 6.1 million under the guidelines written by the panel convened for the Eighth Joint National Committee, according to data presented at the…
Source: www.healio.com
See on Scoop.it – Cardiotoxicity
2012pharmaceutical
Amandeep Kaur
Aashir Awan, Phd
Abhisar Anand
Adina Hazan
Alan F. Kaul, PharmD., MS, MBA, FCCP
alexcrystal6
anamikasarkar
apreconasia
aviralvatsa
David Orchard-Webb, PhD
danutdaagmailcom
Demet Sag, Ph.D., CRA, GCP
Dror Nir
dsmolyar
Ethan Coomber
evelinacohn
Gail S Thornton
Irina Robu
jayzmit48
jdpmd
jshertok
kellyperlman
Ed Kislauskis
larryhbern
Madison Davis
marzankhan
megbaker58
ofermar2020
Dr. Pati
pkandala
Rosalind Codrington, PhD
ritusaxena
Rick Mandahl
sjwilliamspa
Srinivas Sriram
stuartlpbi
Dr. Sudipta Saha
tildabarliya
vaishnavee24
zraviv06
zs22
Leave a Reply